From Dr Tim Reed.

Sir, The Access to Medicines Index (Reports, June 16) was presented as the sober and considered approach amidst the extremities of the pharmaceutical industry and the non-governmental organisation sector. However, the weakness inherent in the design was entirely disregarded.